Loading…
Development Programs – Solid Tumor
Molecule
Indication
Phase 1
Phase 2
Phase 3
Planned for 2024
Development Programs – Hematology
Molecule
Indication
Phase 1
Phase 2
Phase 3
Planned for 2024